Immunogenicity and reactogenicity of BNT162b2 booster in BBIBP-CorV-vaccinated individuals compared with homologous BNT162b2 vaccination: Results of a pilot prospective cohort study from Lebanon

Facing new COVID-19 waves, the effectiveness of BBIBP-CorV has been noted to be low in countries whose populations were already administered two doses of the vaccine. Heterologous vaccination using ChAdOx1-S/BNT162b2 elicited higher immunogenicity compared with homologous immunization. BBIBP-CorV/BN...

Descripción completa

Detalles Bibliográficos
Autores principales: Moghnieh, Rima, Mekdashi, Rana, El-Hassan, Salam, Abdallah, Dania, Jisr, Tamima, Bader, Mohammad, Jizi, Ihab, Sayegh, Mohamed H., Rahman Bizri, Abdul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513356/
https://www.ncbi.nlm.nih.gov/pubmed/34656379
http://dx.doi.org/10.1016/j.vaccine.2021.10.007

Ejemplares similares

Ejemplares similares